RESPONSE OF THE BENIGN HYPERTROPHIED PROSTATE TO TREATMENT WITH AN LHRH ANALOG

被引：38

作者：

KEANE, PF ^{[1
]}

TIMONEY, AG ^{[1
]}

KIELY, E ^{[1
]}

WILLIAMS, G ^{[1
]}

STAMP, G ^{[1
]}

机构：

[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT UROL,DU CANE RD,LONDON W12 0HS,ENGLAND

来源：

BRITISH JOURNAL OF UROLOGY | 1988年 / 62卷 / 02期

关键词：

D O I：

10.1111/j.1464-410X.1988.tb04299.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：163 / 165

页数：3

共 10 条

[1] BIFLURANOL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH) [J].

BEACOCK, CJM ;

BUCK, AC ;

ROBERTS, EE .

PROSTATE, 1985, 7 (04) :357-361

[2] TREATMENT OF BENIGN PROSTATIC HYPERTROPHY WITH FLUTAMIDE (SCH 13521) - PLACEBO-CONTROLLED STUDY [J].

CAINE, M ;

PERLBERG, S ;

GORDON, R .

JOURNAL OF UROLOGY, 1975, 114 (04) :564-568

[3] THE CLINICAL-SIGNIFICANCE OF STEROID-HORMONE MEASUREMENTS IN THE MANAGEMENT OF PATIENTS WITH PROSTATIC-CANCER [J].

GHANADIAN, R ;

PUAH, CM .

WORLD JOURNAL OF UROLOGY, 1983, 1 (01) :49-54

[4] CLINICAL TRIAL OF GESTRONOL HEXANOATE (SH582) IN BENIGN PROSTATIC HYPERTROPHY [J].

GINGELL, JC ;

MILLER, IM ;

ROBERTS, JBM .

PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1972, 65 (02) :130-&

[5] INCIDENCE OF BENIGN PROSTATIC OBSTRUCTION [J].

LYTTON, B ;

EMERY, JM ;

HARVARD, M .

JOURNAL OF UROLOGY, 1968, 99 (05) :639-&

[6] MEDROGESTONE - PROSPECTIVE STUDY IN PHARMACEUTICAL MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA [J].

PAULSON, DF ;

KANE, RD .

JOURNAL OF UROLOGY, 1975, 113 (06) :811-815

[7]

WALSH PC, 1986, CAMPBELLS UROLOGY, V2, P1248

[8]

White J W, 1895, Ann Surg, V22, P1, DOI 10.1097/00000658-189507000-00001

[9]

WILLIAMS G, 1982, ENDOCRINOLOGY PROSTA, P263

[10] THE PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA [J].

WILSON, JD .

AMERICAN JOURNAL OF MEDICINE, 1980, 68 (05) :745-756

← 1 →